Ware; Carl F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ware; Carl F..The latest application filed is for "btla fusion protein agonists and uses thereof".

Company Profile

3.22.21

Ware; Carl F. - La Jolla CA
WARE; Carl F. - Solana Beach CA
Ware; Carl F - Solana Beach CA US
Ware; Carl F. - Riverside CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulation of immune response using BTLA agonist antibodies Grant 11,352,428 - Ware , et al. June 7, 2	2022-06-07
Btla Fusion Protein Agonists And Uses Thereof App 20220025017 - WARE; Carl F. ; et al.	2022-01-27
BTLA fusion protein agonists and uses thereof Grant 10,961,297 - Ware , et al. March 30, 2	2021-03-30
Modulation of .gamma..delta. T cells Grant 10,759,863 - Ware , et al. Sep	2020-09-01
Methods of modulating HVEM, BTLA and CD160 cis complex response or signaling activity with soluble light polypeptide sequences Grant 10,220,081 - Ware , et al.	2019-03-05
Virus vaccination and treatment methods with OX40 agonist compositions Grant 10,106,619 - Croft , et al. October 23, 2	2018-10-23
Btla Fusion Protein Agonists And Uses Thereof App 20180170999 - Ware; Carl F. ; et al.	2018-06-21
Modulation Of Immune Response Using Btla Agonist Antibodies App 20180155426 - WARE; Carl F. ; et al.	2018-06-07
Compositions and methods for treating autoimmune and inflammatory disorders Grant 9,982,023 - Ware , et al. May 29, 2	2018-05-29
Antagonistic human light-specific human monoclonal antibodies Grant 9,771,419 - Granger , et al. September 26, 2	2017-09-26
HVEM/BTLA, HVEM/CD 160 and HVEM/gD cis complexes and methods of use Grant 9,700,606 - Ware , et al. July 11, 2	2017-07-11
Light-mediated anti-cell proliferative compositions and methods Grant 9,694,058 - Ware , et al. July 4, 2	2017-07-04
Modulation Of Gamma Delta T Cells App 20160194403 - WARE; Carl F. ; et al.	2016-07-07
Antagonistic Human Light-specific Human Monoclonal Antibodies App 20150337046 - Granger; Steven W. ; et al.	2015-11-26
Methods For Accelerating Immune Regeneration App 20150266964 - Blazar; Bruce R. ; et al.	2015-09-24
Antagonistic human light-specific human monoclonal antibodies Grant 8,974,787 - Granger , et al. March 10, 2	2015-03-10
Methods Of Modulating Hvem, Btla And Cd160 Cis Complex Response Or Signaling Activity With Soluble Light Polypeptide Sequences App 20140220051 - WARE; CARL F. ; et al.	2014-08-07
Antagonistic Human Light-specific Human Monoclonal Antibodies App 20130230536 - Granger; Steven W. ; et al.	2013-09-05
Compositions And Methods For Treating Autoimmune And Inflammatory Disorders App 20130164306 - Ware; Carl F. ; et al.	2013-06-27
Antagonistic human LIGHT-specific human monoclonal antibodies Grant 8,461,307 - Granger , et al. June 11, 2	2013-06-11
Compositions and methods for modulating responses mediated or associated with BTLA activity Grant 8,349,320 - Ware , et al. January 8, 2	2013-01-08
HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE App 20120251505 - Ware; Carl F. ; et al.	2012-10-04
Virus Vaccination And Treatment Methods With Ox40 Agonist Compositions App 20120141465 - CROFT; MICHAEL ; et al.	2012-06-07
Method for restoring dendritic cell populations Grant 8,153,123 - Ware , et al. April 10, 2	2012-04-10
Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies App 20120076798 - Granger; Steven W. ; et al.	2012-03-29
Antagonistic human LIGHT-specific human monoclonal antibodies Grant 8,058,402 - Granger , et al. November 15, 2	2011-11-15
Hvem/btla, Hvem/cd 160 And Hvem/gd Cis Complexes And Methods Of Use App 20110123551 - Ware; Carl F. ; et al.	2011-05-26
Light-mediated Anti-cell Proliferative Compositions And Methods App 20100136061 - Ware; Carl F. ; et al.	2010-06-03
Methods Of Modulating Hvem, Btla And Cd160 Cis Complex Response Or Signaling Activity With Soluble Light Polypeptide Sequences App 20100129389 - WARE; CARL F. ; et al.	2010-05-27
Us Cip-compositions And Methods For Modulating Responses Mediated Or Associated With Btla Activity App 20100104559 - Ware; Carl F. ; et al.	2010-04-29
Method For Restoring Dendritic Cell Populations App 20100034815 - Ware; Carl F. ; et al.	2010-02-11
Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies App 20100021466 - Granger; Steven W. ; et al.	2010-01-28
Novel Tnf Receptor Regulatory Domain App 20090311280 - Cheung; Timothy C. ; et al.	2009-12-17
Ligand for herpes simplex virus entry mediator and methods of use Grant 7,575,745 - Ware August 18, 2	2009-08-18
Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof App 20070116668 - Browning; Jeffrey L. ; et al.	2007-05-24
Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof Grant 7,030,080 - Browning , et al. April 18, 2	2006-04-18
Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof App 20030143210 - Browning, Jeffrey L. ; et al.	2003-07-31
Lymphotoxin-beta and lymphotoxin-beta complexes Grant 5,795,964 - Browning , et al. August 18, 1	1998-08-18
Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof Grant 5,670,149 - Browning , et al. September 23, 1	1997-09-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.